Skip to Main Content

Advertisement

American Association of Immunologists Journals
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 135, Issue 4
1 October 1985
Issue Cover
ISSN 0022-1767
EISSN 1550-6606
In this Issue

ARTICLES

Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells.
P Wassmer; C Chan; L Lögdberg; E M Shevach
J Immunol (1985) 135 (4): 2237–2242.
View article
PDF
Add to Citation Manager
Activation requirements of cloned inducer T cells. I. Differential inhibition by anti-L3T4 or anti-I-A is determined by the accessory cell population.
R DeKruyff; C Clayberger; H Cantor; M E Dorf
J Immunol (1985) 135 (4): 2243–2248.
View article
PDF
Add to Citation Manager
The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1.
J M Williams; D Deloria; J A Hansen; C A Dinarello; R Loertscher; H M Shapiro; T B Strom
J Immunol (1985) 135 (4): 2249–2255.
View article
PDF
Add to Citation Manager
Antigen-specific T cell activation results in an increase in cytoplasmic free calcium.
D N Shapiro; B S Adams; J E Niederhuber
J Immunol (1985) 135 (4): 2256–2261.
View article
PDF
Add to Citation Manager
Calcium ionophore plus phorbol ester can substitute for antigen in the induction of cytolytic T lymphocytes from specifically primed precursors.
A Truneh; F Albert; P Golstein; A M Schmitt-Verhulst
J Immunol (1985) 135 (4): 2262–2267.
View article
PDF
Add to Citation Manager
Regulatory role of a monomorphic determinant of HLA Class I antigens in T cell proliferation.
M C Turco; M De Felice; L Corbo; G Morrone; R Mertelsmann; S Ferrone; S Venuta
J Immunol (1985) 135 (4): 2268–2273.
View article
PDF
Add to Citation Manager
Presentation of Class I antigens on T cells can induce the generation of antigen-specific CTL.
K S Zier; A R Pickard
J Immunol (1985) 135 (4): 2274–2278.
View article
PDF
Add to Citation Manager
The effects of 1,25-dihydroxyvitamin D3 on human T lymphocyte activation and proliferation: a cell cycle analysis.
W F Rigby; R J Noelle; K Krause; M W Fanger
J Immunol (1985) 135 (4): 2279–2286.
View article
PDF
Add to Citation Manager
Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
D C Flyer; S J Burakoff; D V Faller
J Immunol (1985) 135 (4): 2287–2292.
View article
PDF
Add to Citation Manager
Physiology of IgD. V. Enhancement of antibody responses in vivo by allo anti-IgD is due primarily to an indirect effect on B cells.
E B Jacobson; B Xue; M A O'Neil; G W Siskind; B Pernis; G J Thorbecke
J Immunol (1985) 135 (4): 2293–2298.
View article
PDF
Add to Citation Manager
B lymphocyte production in the bone marrow of mice with X-linked immunodeficiency (xid).
G K Reid; D G Osmond
J Immunol (1985) 135 (4): 2299–2302.
View article
PDF
Add to Citation Manager
Postnatal liver hemopoiesis in mice: generation of pre-B cells, granulocytes, and erythrocytes in discrete colonies.
C E Grossi; A Velardi; M D Cooper
J Immunol (1985) 135 (4): 2303–2311.
View article
PDF
Add to Citation Manager
Suppression and contrasuppression in the induction of contact sensitivity by the administration of cellbound antigen-antibody complexes.
W Ptak; M Bereta; M Ptak; G M Iverson; D R Green
J Immunol (1985) 135 (4): 2312–2318.
View article
PDF
Add to Citation Manager
Carrier-induced epitopic suppression, a major issue for future synthetic vaccines.
M P Schutze; C Leclerc; M Jolivet; F Audibert; L Chedid
J Immunol (1985) 135 (4): 2319–2322.
View article
PDF
Add to Citation Manager
Human monocyte adherence to cultured vascular endothelium: monoclonal antibody-defined mechanisms.
W J Wallis; P G Beatty; H D Ochs; J M Harlan
J Immunol (1985) 135 (4): 2323–2330.
View article
PDF
Add to Citation Manager
Antibodies to Tp67 and Tp44 augment and sustain proliferative responses of activated T cells.
J A Ledbetter; P J Martin; C E Spooner; D Wofsy; T T Tsu; P G Beatty; P Gladstone
J Immunol (1985) 135 (4): 2331–2336.
View article
PDF
Add to Citation Manager
Activation through CD3 molecule leads to clonal expansion of all human peripheral blood T lymphocytes: functional analysis of clonally expanded cells.
W E Weber; W A Buurman; M M Vandermeeren; J C Raus
J Immunol (1985) 135 (4): 2337–2342.
View article
PDF
Add to Citation Manager
The tumor promoter teleocidin induces IL 2 receptor expression and IL 2-independent proliferation of human peripheral blood T cells.
N Isakov; R C Bleackley; J Shaw; A Altman
J Immunol (1985) 135 (4): 2343–2350.
View article
PDF
Add to Citation Manager
Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
H Seki; Y Ueno; K Taga; A Matsuda; T Miyawaki; N Taniguchi
J Immunol (1985) 135 (4): 2351–2356.
View article
PDF
Add to Citation Manager
Competition between antigen and anti-idiotypes for rheumatoid factors.
J L Nelson; F A Nardella; M Mannik
J Immunol (1985) 135 (4): 2357–2361.
View article
PDF
Add to Citation Manager
Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
P Aman; J Gordon; N Lewin; M Nordström; B Ehlin-Henriksson; G Klein; A Carstensson
J Immunol (1985) 135 (4): 2362–2367.
View article
PDF
Add to Citation Manager
Cutaneous mast cell depletion results from topical corticosteroid usage.
R M Lavker; N M Schechter
J Immunol (1985) 135 (4): 2368–2373.
View article
PDF
Add to Citation Manager
Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
H W Murray; R A Gellene; D M Libby; C D Rothermel; B Y Rubin
J Immunol (1985) 135 (4): 2374–2377.
View article
PDF
Add to Citation Manager
Identification of ribosomal protein autoantigens.
A M Francoeur; C L Peebles; K J Heckman; J C Lee; E M Tan
J Immunol (1985) 135 (4): 2378–2384.
View article
PDF
Add to Citation Manager
Specific and shared idiotypes found on hybridoma anti-DNA autoantibodies derived from rheumatoid arthritis and systemic lupus erythematosus patients.
J Rauch; H Massicotte; H Tannenbaum
J Immunol (1985) 135 (4): 2385–2392.
View article
PDF
Add to Citation Manager
Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
R Hohlfeld; B Conti-Tronconi; I Kalies; J Bertrams; K V Toyka
J Immunol (1985) 135 (4): 2393–2399.
View article
PDF
Add to Citation Manager
Characterization of antigens and antibody specificities involved in Heymann nephritis.
K Kamata; L G Baird; M E Erikson; A B Collins; R T McCluskey
J Immunol (1985) 135 (4): 2400–2408.
View article
PDF
Add to Citation Manager
Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
G Camussi; J R Brentjens; B Noble; D Kerjaschki; F Malavasi; O A Roholt; M G Farquhar; G Andres
J Immunol (1985) 135 (4): 2409–2416.
View article
PDF
Add to Citation Manager
Modulation of c-myb transcription in autoimmune disease by cyclophosphamide.
J D Mountz; J F Mushinski; H R Smith; D M Klinman; A D Steinberg
J Immunol (1985) 135 (4): 2417–2422.
View article
PDF
Add to Citation Manager
Functional analysis of T cell subsets from mice bearing the lpr gene.
J L Davignon; R C Budd; R Ceredig; P F Piguet; H R MacDonald; J C Cerottini; P Vassalli; S Izui
J Immunol (1985) 135 (4): 2423–2428.
View article
PDF
Add to Citation Manager
Allogeneic leukocyte and germ cell-induced murine immunodeficiency.
R Raghunathan; T M Mundy; J Faust; S Misra
J Immunol (1985) 135 (4): 2429–2431.
View article
PDF
Add to Citation Manager
Enlargement of Lyt-2-positive T cells is associated with functional impairment and autoimmune hemolytic anemia in New Zealand Black mice.
K L McCoy; P J Baker; T R Malek; T M Chused
J Immunol (1985) 135 (4): 2432–2437.
View article
PDF
Add to Citation Manager
Two defects in old New Zealand Black mice are involved in the loss of low-dose paralysis to type III pneumococcal polysaccharide.
K L McCoy; P J Baker; P W Stashak; T M Chused
J Immunol (1985) 135 (4): 2438–2442.
View article
PDF
Add to Citation Manager
Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule.
P H Wooley; H S Luthra; M M Griffiths; J M Stuart; A Huse; C S David
J Immunol (1985) 135 (4): 2443–2451.
View article
PDF
Add to Citation Manager
Analysis of lymphocytes infiltrating the thyroid gland of Obese strain chickens.
G Krömer; R S Sundick; K Schauenstein; K Hála; G Wick
J Immunol (1985) 135 (4): 2452–2457.
View article
PDF
Add to Citation Manager
In vitro T cell hyperreactivity in Obese strain (OS) chickens is due to a defect in nonspecific suppressor mechanism(s).
G Krömer; K Schauenstein; N Neu; K Stricker; G Wick
J Immunol (1985) 135 (4): 2458–2463.
View article
PDF
Add to Citation Manager
Interaction of interleukin 2 with cells: quantitative analysis of effects.
J W Hooton; C Gibbs; V Paetkau
J Immunol (1985) 135 (4): 2464–2473.
View article
PDF
Add to Citation Manager
Interleukin 2 acts directly on a Tac-positive cloned B cell line established from a patient with adult T cell leukemia.
N Arima; Y Daitoku; S Hidaka; H Tanaka; T Katsuki
J Immunol (1985) 135 (4): 2474–2477.
View article
PDF
Add to Citation Manager
Monoclonal antibody OKT11A inhibits and recombinant interleukin 2 (IL 2) augments expression of IL 2 receptors at a pretranslational level.
J C Reed; W C Greene; R G Hoover; P C Nowell
J Immunol (1985) 135 (4): 2478–2482.
View article
PDF
Add to Citation Manager
Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2.
J E Talmadge; R B Herberman; M A Chirigos; A E Maluish; M A Schneider; J S Adams; H Philips; G B Thurman; L Varesio; C Long
J Immunol (1985) 135 (4): 2483–2491.
View article
PDF
Add to Citation Manager
Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta.
G E Nedwin; L P Svedersky; T S Bringman; M A Palladino, Jr; D V Goeddel
J Immunol (1985) 135 (4): 2492–2497.
View article
PDF
Add to Citation Manager
Gamma-interferon enhances expression of Class I MHC antigens in the weakly HLA+ human choriocarcinoma cell line BeWo, but does not induce MHC expression in the HLA- choriocarcinoma cell line Jar.
D J Anderson; R S Berkowitz
J Immunol (1985) 135 (4): 2498–2501.
View article
PDF
Add to Citation Manager
The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
H E Broxmeyer; S Cooper; B Y Rubin; M W Taylor
J Immunol (1985) 135 (4): 2502–2506.
View article
PDF
Add to Citation Manager
Studies of interferon as a regulator of hematopoietic cell proliferation.
E L Raefsky; L C Platanias; N C Zoumbos; N S Young
J Immunol (1985) 135 (4): 2507–2512.
View article
PDF
Add to Citation Manager
Recombinant interferon-gamma inhibits the B cell proliferative response stimulated by soluble but not by Sepharose-bound anti-immunoglobulin antibody.
J J Mond; F D Finkelman; C Sarma; J Ohara; S Serrate
J Immunol (1985) 135 (4): 2513–2517.
View article
PDF
Add to Citation Manager
Partial purification of murine B cell stimulatory factor (BSF)-1.
J Ohara; S Lahet; J Inman; W E Paul
J Immunol (1985) 135 (4): 2518–2523.
View article
PDF
Add to Citation Manager
A naturally occurring polyclonal B cell activator of normal and autoantibody responses.
M J Atkinson; D A Bell; S K Singhal
J Immunol (1985) 135 (4): 2524–2533.
View article
PDF
Add to Citation Manager
Role of N-acetyl-D-galactosamine residue on B151K12-derived T cell-replacing factor (B151-TRF) molecule in B cell-receptor binding and -stimulating activity.
Y Takahama; S Ono; Y Hara; S Hayashi; K Dobashi; T Hamaoka
J Immunol (1985) 135 (4): 2534–2540.
View article
PDF
Add to Citation Manager
Functional recognition of bacterial mitogens by B lymphoma cells: reactivity of WEHI 279.1 to lipopolysaccharide and selection of nonreactive variants.
B Kleine; A Coutinho
J Immunol (1985) 135 (4): 2541–2545.
View article
PDF
Add to Citation Manager
Activation of murine spleen cells by lipid A: negative modulation of lipid A mitogenic activity by O-antigen polysaccharide.
S W Vukajlovich; D C Morrison
J Immunol (1985) 135 (4): 2546–2550.
View article
PDF
Add to Citation Manager
Production of soluble suppressor factor by spleen cells from mice immunized with type III pneumococcal polysaccharide.
C E Taylor; P J Baker
J Immunol (1985) 135 (4): 2551–2556.
View article
PDF
Add to Citation Manager
Recipient micro-environment does not dictate the Igh-V restriction specificity of T cell suppressor inducer factor (TsiF) from allogeneic bone marrow chimera in mice.
M Noguchi; M Ogasawara; K Iwabuchi; K Osgasawara; T Ishihara; R A Good; K Morikawa; K Onoé
J Immunol (1985) 135 (4): 2557–2561.
View article
PDF
Add to Citation Manager
Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.
F E Dewhirst; P P Stashenko; J E Mole; T Tsurumachi
J Immunol (1985) 135 (4): 2562–2568.
View article
PDF
Add to Citation Manager
The effects of vasoactive intestinal peptide on human natural killer cell function.
M Rola-Pleszczynski; D Bolduc; S St-Pierre
J Immunol (1985) 135 (4): 2569–2573.
View article
PDF
Add to Citation Manager
Noncovalent association of heavy and light chains of human immunoglobulins. IV. The roles of the CH1 and CL domains in idiotypic expression.
A Rinfret; C Horne; K J Dorrington; M Klein
J Immunol (1985) 135 (4): 2574–2581.
View article
PDF
Add to Citation Manager
Immunogenicity of a synthetic glucosyl-alpha(1,3)-glucosyl protein conjugate.
T V Tittle; A Mawle; M Cohn
J Immunol (1985) 135 (4): 2582–2588.
View article
PDF
Add to Citation Manager
Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies.
B Akerström; T Brodin; K Reis; L Björck
J Immunol (1985) 135 (4): 2589–2592.
View article
PDF
Add to Citation Manager
Effect of antibody excess on the size, stoichiometry, and DNAse resistance of DNA anti-DNA immune complexes.
G Burdick; W Emlen
J Immunol (1985) 135 (4): 2593–2597.
View article
PDF
Add to Citation Manager
The T lymphocyte response to cytochrome c. V. Determination of the minimal peptide size required for stimulation of T cell clones and assessment of the contribution of each residue beyond this size to antigenic potency.
R H Schwartz; B S Fox; E Fraga; C Chen; B Singh
J Immunol (1985) 135 (4): 2598–2608.
View article
PDF
Add to Citation Manager
Monoclonal antibodies to horse cytochrome c expressing four distinct idiotypes distribute among two sites on the native protein.
F R Carbone; Y Paterson
J Immunol (1985) 135 (4): 2609–2616.
View article
PDF
Add to Citation Manager
Lipid-induced recognition of a conformational determinant (residues 65 to 83) in myelin basic protein.
J M Boggs; G A Hashim; E D Day; M A Moscarello
J Immunol (1985) 135 (4): 2617–2622.
View article
PDF
Add to Citation Manager
Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies.
K Ogata; Y Ogata; R M Nakamura; E M Tan
J Immunol (1985) 135 (4): 2623–2627.
View article
PDF
Add to Citation Manager
T cell clones to two major T cell epitopes of myoglobin: effect of I-A/I-E restriction on epitope dominance.
I Berkower; H Kawamura; L A Matis; J A Berzofsky
J Immunol (1985) 135 (4): 2628–2634.
View article
PDF
Add to Citation Manager
Biochemical characterization of murine lymphoid alloantigen Ly-m20.2, a cell surface marker controlled by a gene linked to the Mls locus.
W H Mark; S Kimura; U Hämmerling
J Immunol (1985) 135 (4): 2635–2641.
View article
PDF
Add to Citation Manager
Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.
R W Karr; L K Lipman; C Alber; F Koning; N E Goeken
J Immunol (1985) 135 (4): 2642–2646.
View article
PDF
Add to Citation Manager
An antibody binding to human neutrophils demonstrates antigenic heterogeneity detected early in myeloid maturation which correlates with functional heterogeneity of mature neutrophils.
B Seligmann; H L Malech; D A Melnick; J I Gallin
J Immunol (1985) 135 (4): 2647–2653.
View article
PDF
Add to Citation Manager
Fine specificity, structure, and proteolytic susceptibility of the human lymphocyte receptor for IgE.
L H Peterson; D H Conrad
J Immunol (1985) 135 (4): 2654–2660.
View article
PDF
Add to Citation Manager
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
T Seya; V M Holers; J P Atkinson
J Immunol (1985) 135 (4): 2661–2667.
View article
PDF
Add to Citation Manager
Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
R Rothlein; T A Springer
J Immunol (1985) 135 (4): 2668–2672.
View article
PDF
Add to Citation Manager
Factor I co-factor activity of CR1 overcomes the protective effect of IgG on covalently bound C3b residues.
L F Fries; G M Prince; T A Gaither; M M Frank
J Immunol (1985) 135 (4): 2673–2679.
View article
PDF
Add to Citation Manager
Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1).
J F Bohnsack; J J O'Shea; T Takahashi; E J Brown
J Immunol (1985) 135 (4): 2680–2686.
View article
PDF
Add to Citation Manager
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
M Reynes; J P Aubert; J H Cohen; J Audouin; V Tricottet; J Diebold; M D Kazatchkine
J Immunol (1985) 135 (4): 2687–2694.
View article
PDF
Add to Citation Manager
Antibody-independent activation of C1, the first component of complement, by cardiolipin.
T Kovacsovics; J Tschopp; A Kress; H Isliker
J Immunol (1985) 135 (4): 2695–2700.
View article
PDF
Add to Citation Manager
Enhancement by cyclic AMP of antibody-induced suppression of the fourth component of complement.
M B Goldman; D S Becker; K S O'Rourke; J N Goldman
J Immunol (1985) 135 (4): 2701–2706.
View article
PDF
Add to Citation Manager
Endogenous somatostatin-like peptides of rat basophilic leukemia cells.
E J Goetzl; T Chernov-Rogan; M P Cooke; F Renold; D G Payan
J Immunol (1985) 135 (4): 2707–2712.
View article
PDF
Add to Citation Manager
Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
D G Sawutz; D Sylvestre; C J Homcy
J Immunol (1985) 135 (4): 2713–2718.
View article
PDF
Add to Citation Manager
Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids.
J L Robin; D C Seldin; K F Austen; R A Lewis
J Immunol (1985) 135 (4): 2719–2726.
View article
PDF
Add to Citation Manager
Relationship among IgE-binding factors with various molecular weights.
P Jardieu; K Moore; C Martens; K Ishizaka
J Immunol (1985) 135 (4): 2727–2734.
View article
PDF
Add to Citation Manager
The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration.
L Håkansson; P Venge
J Immunol (1985) 135 (4): 2735–2739.
View article
PDF
Add to Citation Manager
The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
D L Hamilos; H J Wedner
J Immunol (1985) 135 (4): 2740–2747.
View article
PDF
Add to Citation Manager
Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells.
F Bussolino; M Aglietta; F Sanavio; A Stacchini; D Lauri; G Camussi
J Immunol (1985) 135 (4): 2748–2753.
View article
PDF
Add to Citation Manager
Immunosuppressive effects of benzidine in mice: evidence of alterations in arachidonic acid metabolism.
M I Luster; A N Tucker; H T Hayes; O J Pung; T Burka; R McMillan; T Eling
J Immunol (1985) 135 (4): 2754–2761.
View article
PDF
Add to Citation Manager
The fibrinogenolytic activity of purified tryptase from human lung mast cells.
L B Schwartz; T R Bradford; B H Littman; B U Wintroub
J Immunol (1985) 135 (4): 2762–2767.
View article
PDF
Add to Citation Manager
Production of the lymphokine soluble immune response suppressor (SIRS) during chronic experimental schistosomiasis mansoni.
T M Aune; G L Freeman, Jr; D G Colley
J Immunol (1985) 135 (4): 2768–2771.
View article
PDF
Add to Citation Manager
Protective monoclonal antibody against Schistosoma mansoni: antigen isolation, characterization, and suitability for active immunization.
R T Hazdai; F Levi-Schaffer; V Brenner; S Horowitz; Z Eshhar; R Arnon
J Immunol (1985) 135 (4): 2772–2779.
View article
PDF
Add to Citation Manager
Fc gamma receptors on rat eosinophils: isotype-dependent cell activation.
J Khalife; M Capron; J M Grzych; H Bazin; A Capron
J Immunol (1985) 135 (4): 2780–2784.
View article
PDF
Add to Citation Manager
The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
D M Mosser; P J Edelson
J Immunol (1985) 135 (4): 2785–2789.
View article
PDF
Add to Citation Manager
Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites.
F Zavala; A Masuda; P M Graves; V Nussenzweig; R S Nussenzweig
J Immunol (1985) 135 (4): 2790–2793.
View article
PDF
Add to Citation Manager
In vitro parasite antigen-induced antibody responses in human helminth infections.
T B Nutman; A S Withers; E A Ottesen
J Immunol (1985) 135 (4): 2794–2799.
View article
PDF
Add to Citation Manager
Recognition of viral antigens by human influenza A virus-specific T lymphocyte clones.
B Fleischer; H Becht; R Rott
J Immunol (1985) 135 (4): 2800–2804.
View article
PDF
Add to Citation Manager
Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
J J Schlesinger; M W Brandriss; E E Walsh
J Immunol (1985) 135 (4): 2805–2809.
View article
PDF
Add to Citation Manager
Isoelectric focusing of human antibody to the Haemophilus influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults.
R A Insel; A Kittelberger; P Anderson
J Immunol (1985) 135 (4): 2810–2816.
View article
PDF
Add to Citation Manager
Stimulation of a cell-mediated cytotoxic response to FeLV-induced T cell lymphomas in the cat.
M B Tompkins; W A Tompkins
J Immunol (1985) 135 (4): 2817–2823.
View article
PDF
Add to Citation Manager
Immunity to leprosy. II. Genetic control of murine T cell proliferative responses to Mycobacterium leprae.
A G Douglas-Jones; J D Watson
J Immunol (1985) 135 (4): 2824–2828.
View article
PDF
Add to Citation Manager
Adoptive transfer of anti-syphilis immunity with lymphocytes from Treponema pallidum-infected guinea pigs.
C S Pavia; C J Niederbuhl
J Immunol (1985) 135 (4): 2829–2834.
View article
PDF
Add to Citation Manager
Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype.
E P Cowan; B R Jordan; J E Coligan
J Immunol (1985) 135 (4): 2835–2841.
View article
PDF
Add to Citation Manager
Allograft rejection-defined antigens of the B2m,H-3 region.
R J Graff; D Martin-Morgan; M E Kurtz
J Immunol (1985) 135 (4): 2842–2846.
View article
PDF
Add to Citation Manager
CTL and serologically defined antigens of B2m,H-3 region.
M E Kurtz; R J Graff; A Adelman; D Martin-Morgan; R E Click
J Immunol (1985) 135 (4): 2847–2852.
View article
PDF
Add to Citation Manager
Identical RT1 class II molecules are expressed by rat RT1m and RT1c haplotypes.
J A Sawicki; J G Frelinger; M Palmer; D A Buck; B Dietzschold; P J Wettstein
J Immunol (1985) 135 (4): 2853–2858.
View article
PDF
Add to Citation Manager
The regulation of membrane-bound and secreted alpha-chain biosynthesis during the differentiation of the B cell lymphoma I.29.
R Sitia; A Rubartelli; H Kikutani; U Hammerling; J Stavnezer
J Immunol (1985) 135 (4): 2859–2864.
View article
PDF
Add to Citation Manager
In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.
M T Lotze; Y L Matory; S E Ettinghausen; A A Rayner; S O Sharrow; C A Seipp; M C Custer; S A Rosenberg
J Immunol (1985) 135 (4): 2865–2875.
View article
PDF
Add to Citation Manager
In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
D Kabelitz; K Pfeffer; D von Steldern; P Bartmann; O Brudler; C Nerl; H Wagner
J Immunol (1985) 135 (4): 2876–2881.
View article
PDF
Add to Citation Manager
The role of interleukin 1 (IL 1) in tumor-NK cell interactions: correction of defective NK cell activity in cancer patients by treating target cells with IL 1.
J Herman; C A Dinarello; M C Kew; A R Rabson
J Immunol (1985) 135 (4): 2882–2886.
View article
PDF
Add to Citation Manager
Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon.
P Giacomini; L Imberti; A Aguzzi; P B Fisher; G Trinchieri; S Ferrone
J Immunol (1985) 135 (4): 2887–2894.
View article
PDF
Add to Citation Manager
Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
S Shu; S A Rosenberg
J Immunol (1985) 135 (4): 2895–2903.
View article
PDF
Add to Citation Manager

ERRATA

Type II collagen-reactive T cell clones from mice with collagen-induced arthritis
M Dallman; RL Smith; CG Fathman
J Immunol (1985) 135 (4): 2904.
View article
PDF
Add to Citation Manager
All Issues

Advertisement

Advertisement

Advertisement

  • Online ISSN 1550-6606
  • Print ISSN 0022-1767

Publications

Submit a Manuscript

General Information

Journal Services

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal